Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 119

Sort by

Sort Order Select

Journal Articles

A Meta-Analysis Evaluating the Risk of Bleeding-Related Adverse Events with Defibrotide Treatment

William Tappe, Saurabh Aggarwal, Ozlem Topaloglu, Massimo Iacobelli

Blood (2019) 134 (Supplement_1): 2016.

https://doi.org/10.1182/blood-2019-123686

Published: 2019

Journal Articles

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Christopher Pleyer, MD, Jeffrey Cohen, MD, Susan Soto, Mir Ali, PhD, Inhye E Ahn, MD, Pia Nierman, BSN, MA, RN, Janet Valdez, Jennifer Lotter, PA-C, Jeanine Superata, RN, Xin Tian, Adrian Wiestner, MD PhD, Clare Sun, MD

Blood (2019) 134 (Supplement_1): 3053.

https://doi.org/10.1182/blood-2019-121675

Published: 2019

Journal Articles

Telomere Elongation and Clinical Improvement in Telomeropathy Patients: A Prospective Clinical Trial of Nandrolone in Telomeropathies

Diego V Clé, MD PhD, Luiz Fernando Catto, MD, Luiz Guilherme Darrigo, PhD, Elvis Valera, Fernanda Gutierrez-Rodrigues, PhD, Flavia S. Donaires, PhD, André Pinto, Renan C. Albino, Bárbara Santana, Jose Baddini-Martinez, MD PhD, Rodrigo T. Calado, MD PhD

Blood (2019) 134 (Supplement_1): 2501.

https://doi.org/10.1182/blood-2019-130844

Published: 2019

Journal Articles

A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Healthy Adults

Martha Hernandez-Illas, Tong Lin, Andres Rey, Jack Jenkins, Reddy Chandula, Mi Rim Choi, MD

Blood (2019) 134 (Supplement_1): 3817.

https://doi.org/10.1182/blood-2019-123695

Published: 2019

Journal Articles

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Abishek Vaidya, MS, Erin E Doherty, MD, Xiya Wu, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD

Blood (2019) 134 (Supplement_1): 4441.

https://doi.org/10.1182/blood-2019-125395

Published: 2019

Journal Articles

Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens ( RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to Escherichia coli -Derived Asparaginases

Luke Maese, DO, Rachel E. Rau, MD, Elizabeth A. Raetz, MD, Tong Lin, Jin Zhu, Pil Kim, Reddy Chandula, Sherrie McClung, Julie Gray, Mi Rim Choi, MD, Mignon L. Loh, MD, Peter C. Adamson

Blood (2019) 134 (Supplement_1): 2586.

https://doi.org/10.1182/blood-2019-123710

Published: 2019

Journal Articles

Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation

Francesco Iuliano, MD, Eleonora Iuliano, MD, Marco Rossi, MD

Blood (2018) 132 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2018-99-118518

Published: 2018

Journal Articles

Clinical Impact of Pre-Transplant Intramuscular Adipose Tissue Content on Outcome of Cord Blood Transplantation

Shuhei Kurosawa, MD, Yuichi Takeuchi, Marina Matsui, Masao Tsukada, Kanichi Iwama, Kazunari Yamada, Kouichi Kaziwara, Hideki Kodo, Yasuzi Kouzai

Blood (2018) 132 (Supplement 1): 3392.

https://doi.org/10.1182/blood-2018-99-110691

Published: 2018

Journal Articles

Appropriateness of B12 Administration in a Real-World Population

William K Silverstein, MD, Yulia Lin, MD FRCPC, Christoffer Dharma, MSc, Ruth Croxford, MSc, Matthew Cheung, MD MS, FRCP

Blood (2018) 132 (Supplement 1): 2227.

https://doi.org/10.1182/blood-2018-99-110264

Published: 2018

Journal Articles

Prospective, Multi-Center, Phase I Clinical Trial of PLX-R18 Placental Expanded Adherent Stromal Cells in Subjects with Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation

Hillard M Lazarus, MD, Leland Metheny, MD, Tsila Zuckerman, MD, Carolina Escobar, MD, Joseph P. McGuirk, DO, Yael Rosen, MD, Jacob M. Rowe, MD

Blood (2018) 132 (Supplement 1): 3379.

https://doi.org/10.1182/blood-2018-99-116239

Published: 2018

Journal Articles

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, Andres Gomez De Leon, MD, Diana E Garcia-Camarillo, MD, Oscar Marquez-Pinedo, MD, Paola Santana-Hernandez, MD, Olga Cantu Rodriguez, MD, Cesar Homero Gutierrez Aguirre, MD, Luz del Carmen Tarín Arzaga, MD, David Gomez-Almaguer, MD

Blood (2018) 132 (Supplement 1): 1043.

https://doi.org/10.1182/blood-2018-99-118611

Published: 2018

Journal Articles

Pegaspargase with Concurrent Radiotherapy in a Once-Every-Three-Weeks Schedule in Patients with Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: A Phase II Study

Hua Wang, MD, Wei Luo, Yue Lu

Blood (2018) 132 (Supplement 1): 2928.

https://doi.org/10.1182/blood-2018-99-113265

Published: 2018

Journal Articles

Efficacy of Iron Therapy on Fatigue and Work Capacity in Non-Anemic Iron Deficient Adults: A Systematic Review of Randomized Controlled Trials

Brett L. Houston, MD, Daryl Hurrie, MSc, Jeff Graham, MD, Brittany Perija, MD, Emily Rimmer, MD, Rasheda Rabbani, PhD, Charles N. Bernstein, MD, Alexis Turgeon, MD, Dean Fergusson, PhD, Donald S. Houston, MD PhD, Ahmed M. Abou-Setta, MD PhD, Ryan Zarychanski, MD

Blood (2017) 130 (Supplement 1): 3497.

https://doi.org/10.1182/blood.V130.Suppl_1.3497.3497

Published: 2017

Journal Articles

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Sarayu Kumar, BA, BSPH, Curtis D Travers, MPH, John Bergsagel, MD, Frank G Keller, MD, Melinda Pauly, MD, Himalee Sabnis, MDMS, Sharon M. Castellino, MD MSc, Glen Lew, MD

Blood (2017) 130 (Supplement 1): 100.

https://doi.org/10.1182/blood.V130.Suppl_1.100.100

Published: 2017

Journal Articles

Innate Immune Activation Via TLR9 May Enhance Antibody Formation Against Factors VIII and IX in Protein and Gene Therapy

Roland W Herzog, PhD, Alexandra Sherman, DVM, Brad E. Hoffman, PhD

Blood (2017) 130 (Supplement 1): 3651.

https://doi.org/10.1182/blood.V130.Suppl_1.3651.3651

Published: 2017

Journal Articles

Intramuscular Administration of Placenta-Derived Stromal Cells Enhances Survival of Rhesus Macaque Monkeys Exposed to Total Body Irradiation

Noa Sher, PhD, Tal Prezma, Dana Fuchs-Telem, Niva Shraga- Heled, Simon Authier, Polly Chang, Alexis Ascah, James Bakke, Janet Gahagen, Racheli Ofir, PhD

Blood (2017) 130 (Supplement 1): 3784.

https://doi.org/10.1182/blood.V130.Suppl_1.3784.3784

Published: 2017

Journal Articles

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Hua Wang, PhD, Xiao-qin Chen, Wei-da Wang, Zhong-jun Xia, MD

Blood (2017) 130 (Supplement 1): 2787.

https://doi.org/10.1182/blood.V130.Suppl_1.2787.2787

Published: 2017

Journal Articles

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Kah-Whye Peng, PhD, Linh Pham, Lianwen Zhang, PhD, Rebecca Nace, Nathan Jenks, Michael Steele, Alysha Newsom, Ronald Marler, DVM, PhD, Martha Q Lacy, MD, Stephen J. Russell, MD PhD

Blood (2017) 130 (Supplement 1): 1807.

https://doi.org/10.1182/blood.V130.Suppl_1.1807.1807

Published: 2017

Journal Articles

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Katie Zomorodi, PhD, Todd Dumas, PharmD, Seth Berry, PharmD, Curtis Johnston, PharmD, Mark Eller, PhD

Blood (2016) 128 (22): 1631.

https://doi.org/10.1182/blood.V128.22.1631.1631

Published: 2016

Journal Articles

Final Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Ajay K Nooka, MD MPH, Michael Wang, MD, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth K. O'Donnell, MD, Jatin J. Shah, MD, Jonathan L. Kaufman, MD, Doris Peterkin, MBA, Sagar Lonial, MD FACP, Paul G. Richardson, MD, Noopur Raje, MD

Blood (2016) 128 (22): 2124.

https://doi.org/10.1182/blood.V128.22.2124.2124

Published: 2016

NARROW

A Meta-Analysis Evaluating the Risk of Bleeding-Related Adverse Events with Defibrotide Treatment

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Telomere Elongation and Clinical Improvement in Telomeropathy Patients: A Prospective Clinical Trial of Nandrolone in Telomeropathies

A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Healthy Adults

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens ( RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to Escherichia coli -Derived Asparaginases

Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation

Clinical Impact of Pre-Transplant Intramuscular Adipose Tissue Content on Outcome of Cord Blood Transplantation

Appropriateness of B12 Administration in a Real-World Population

Prospective, Multi-Center, Phase I Clinical Trial of PLX-R18 Placental Expanded Adherent Stromal Cells in Subjects with Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation

Newly Diagnosed Pernicious Anemia Can be Treated with a Single Megadose of Cobalamin. Results of a Pilot Trial

Pegaspargase with Concurrent Radiotherapy in a Once-Every-Three-Weeks Schedule in Patients with Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: A Phase II Study

Efficacy of Iron Therapy on Fatigue and Work Capacity in Non-Anemic Iron Deficient Adults: A Systematic Review of Randomized Controlled Trials

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Innate Immune Activation Via TLR9 May Enhance Antibody Formation Against Factors VIII and IX in Protein and Gene Therapy

Intramuscular Administration of Placenta-Derived Stromal Cells Enhances Survival of Rhesus Macaque Monkeys Exposed to Total Body Irradiation

Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma: a Phase II Clinical Trial

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Final Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only